Sanofi Pasteur Vaccine Manufacturing Violations Cited In FDA Warning Letter
This article was originally published in The Pink Sheet Daily
Executive Summary
Sterility issues at the firm's Swiftwater, Pa. manufacturing facility should not impact supplies of the Fluzone influenza vaccine, FDA says.